Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$1.99 - $2.45 $963 - $1,185
-484 Reduced 8.84%
4,994 $11,000
Q2 2023

Aug 07, 2023

BUY
$2.1 - $3.36 $2,610 - $4,176
1,243 Added 29.35%
5,478 $12,000
Q1 2023

May 08, 2023

SELL
$2.13 - $3.6 $2,249 - $3,801
-1,056 Reduced 19.96%
4,235 $10,000
Q4 2022

Feb 01, 2023

BUY
$2.05 - $3.47 $6,020 - $10,191
2,937 Added 124.77%
5,291 $13,000
Q3 2022

Nov 10, 2022

BUY
$0.63 - $5.47 $587 - $5,098
932 Added 65.54%
2,354 $6,000
Q2 2022

Aug 03, 2022

SELL
$4.27 - $8.26 $12,600 - $24,375
-2,951 Reduced 67.48%
1,422 $6,000
Q1 2022

May 04, 2022

BUY
$7.07 - $11.62 $8,745 - $14,373
1,237 Added 39.45%
4,373 $35,000
Q4 2021

Feb 09, 2022

BUY
$10.49 - $14.28 $32,896 - $44,782
3,136 New
3,136 $36,000

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.